These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 45285)

  • 21. [Effect of beta-blocking agents talinolol and metipranolol in patients with thyrotoxicosis (author's transl)].
    Nedvídková J; Cenková V; Felt V
    Cas Lek Cesk; 1980 Jul; 119(27-28):749-51. PubMed ID: 6107177
    [No Abstract]   [Full Text] [Related]  

  • 22. Compared effect of propranolol and acebutolol on serum thyroid hormones' levels in euthyroid and hyperthyroid patients: a randomized study.
    Perret G; Hugues JN; Modigliani E; Sebaoun J
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):360-4. PubMed ID: 6469425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent.
    Ljunggren JG; Persson B
    Acta Chir Scand; 1975; 141(8):715-8. PubMed ID: 3081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.
    Nilsson OR; Melander A; Tegler L
    Eur J Clin Pharmacol; 1980 Oct; 18(4):315-20. PubMed ID: 7439251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of propranolol on the plasma cyclic AMP and cyclic GMP levels to massive doses of glucagon in euthyroid and hyperthyroid subjects.
    Földes J; Gyertyánfy G; Piroska E; Juhász J
    Acta Med Acad Sci Hung; 1977; 34(4):227-34. PubMed ID: 218419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of various beta-adrenolytic drugs and calcium channel blockers (nifedipine) on serum levels of T3 and T4 in patients with hyperthyroidism and simple goiter].
    Gasińska T; Nowak S; Izbicka M; Szydło E
    Endokrynol Pol; 1988; 39(3):119-27. PubMed ID: 2907475
    [No Abstract]   [Full Text] [Related]  

  • 28. [The treatment of thyrotoxicosis with beta-blocking agents].
    Dogliotti L; Fonzo D; Lauro R; De Martinis C
    Minerva Med; 1971 Oct; 62(77):3679-84. PubMed ID: 4398567
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
    Weth G; Schneider J; Rodatz H; Haubitz I
    Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers in thyrotoxicosis.
    Lancet; 1980 Jan; 1(8161):184-6. PubMed ID: 6153439
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects.
    Ross PJ; Jones MK; John R
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):27-31. PubMed ID: 7438461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta adrenergic blockade and subtotal thyroidectomy in thyrotoxic patients. A preliminary uncontrolled study].
    Clementsen HJ; Gronbaek P; Guldhammer EH; Knudsen J; Spotoft H; Toft H
    Ugeskr Laeger; 1976 Nov; 138(47):2950-3. PubMed ID: 982646
    [No Abstract]   [Full Text] [Related]  

  • 34. Propranolol as primary therapy for thyrotoxicosis.
    Mazzaferri EL; Reynolds JC; Young RL; Thomas CN; Parisi AF
    Arch Intern Med; 1976 Jan; 136(1):50-6. PubMed ID: 1108824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of celiprolol compared to propranolol on thyroid metabolism].
    Langsteger W; Lind P; Eber O
    Wien Med Wochenschr; 1985 Sep; 135(18):451-7. PubMed ID: 2865857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P
    Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of nadolol in hyperthyroidism].
    Opocher G; Girelli ME; Moro A; Rampazzo T; Busnardo B; Mantero F
    Clin Ter; 1985 Apr; 113(2):99-103. PubMed ID: 4017498
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of D- versus L-propranolol in the treatment of hyperthyroidism.
    Eber O; Buchinger W; Lindner W; Lind P; Rath M; Klima G; Langsteger W; Költringer P
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):363-72. PubMed ID: 2344697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
    Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
    Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
    Perrild H; Hansen JM; Skovsted L; Christensen LK
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):139-42. PubMed ID: 6133659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.